Rennova Health, Inc. (NASDAQ:RNVA) Files An 8-K Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.

(d)Exhibits

Rennova Health, Inc. Exhibit
EX-99.1 2 ex99-1.htm     RENNOVA HEALTH WITHDRAWS PROPOSAL FOR A REVERSE STOCK SPLIT AT UPCOMING SHAREHOLDERS MEETING AND URGES SHAREHOLDERS TO VOTE “FOR” AND APPROVE THE REMAINING PROPOSALS   WEST PALM BEACH,…
To view the full exhibit click here

About Rennova Health, Inc. (NASDAQ:RNVA)

Rennova Health, Inc. (Rennova), formerly CollabRx, Inc., is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers. Rennova’s principal line of business is clinical laboratory blood and urine testing services. It is also engaged in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. Its clinical laboratories include Biohealth Medical Laboratory, Inc.; Alethea Laboratories, Inc.; International Technologies, LLC; EPIC Reference Labs, Inc., and Epinex Diagnostics Laboratories, Inc.